POSTMARKETING SURVEILLANCE OF ENALAPRIL .1. RESULTS OF PRESCRIPTION-EVENT MONITORING

被引：96

作者：

INMAN, WHW ^{[1
]}

RAWSON, NSB ^{[1
]}

WILTON, LV ^{[1
]}

PEARCE, GL ^{[1
]}

SPEIRS, CJ ^{[1
]}

机构：

[1] ROYAL POSTGRAD MED SCH,DEPT CLIN PHARMACOL,LONDON W12 0NN,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1988年 / 297卷 / 6652期

关键词：

D O I：

10.1136/bmj.297.6652.826

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：826 / 829

页数：4

共 10 条

[1]

COOPER WD, 1987, J ROY COLL GEN PRACT, V37, P346

[2] COUGH ASSOCIATED WITH CAPTOPRIL AND ENALAPRIL [J].

COULTER, DM ;

EDWARDS, IR .

BRITISH MEDICAL JOURNAL, 1987, 294 (6586) :1521-1523

[3] ADVERSE REACTIONS WITH ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS [J].

DIBIANCO, R .

MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (02) :122-141

[4]

EDWARDS JR, 1987, BR J CLIN PHARM, V23, P529

[5] REVIEW OF THE OVERALL EXPERIENCE OF CAPTOPRIL IN HYPERTENSION [J].

FROHLICH, ED ;

COOPER, RA ;

LEWIS, EJ .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (07) :1441-1444

[6]

INMAN WHW, 1986, LANCET, V2, P1218

[7]

INMAN WHW, 1986, MONITORING DRUG SAFE, P213

[8] SAFETY PROFILES OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS CAPTOPRIL AND ENALAPRIL [J].

IRVIN, JD ;

VIAU, JM .

AMERICAN JOURNAL OF MEDICINE, 1986, 81 (4C) :46-50

[9]

JENKINS AC, 1985, J CARDIOVASC PHARM, V7, P96

[10] POSTMARKETING SURVEILLANCE OF ENALAPRIL .2. INVESTIGATION OF THE POTENTIAL ROLE OF ENALAPRIL IN DEATHS WITH RENAL-FAILURE [J].

SPEIRS, CJ ;

DOLLERY, CT ;

INMAN, WHW ;

RAWSON, NSB ;

WILTON, LV .

BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6652) :830-832

← 1 →